Abstract Hepatocellular carcinoma (HCC) accounts for most primary liver cancers and displays substantial variability in survival outcomes. Existing staging systems, such as the American Joint Committee on Cancer (AJCC), Barcelona Clinic Liver Cancer (BCLC), and China Liver Cancer Staging (CNLC) systems, often fail to capture individual heterogeneity.